Navigation Links
Epilepsy researcher at the Children's Hospital of Philadelphia receives scientific prize

Douglas A. Coulter, Ph.D., a neuroscientist at The Children's Hospital of Philadelphia, received the 2010 Epilepsy Research Recognition Award for Basic Science from the American Epilepsy Society. The Society honored Dr. Coulter's pioneering contributions to epilepsy research on Monday, Dec. 6 at its Annual Meeting in San Antonio.

Considered the most prestigious prizes for research in epilepsy, the Epilepsy Research Recognition Awards annually honor active scientists for professional excellence and distinguished research. One award recognizes a basic science investigator, the other a clinical investigator.

The Basic Science Award to Dr. Coulter acknowledges his "highly original and pioneering contributions to the understanding of altered brain cell and circuit function in the development of epilepsy." He has studied a fundamental research questionhow does an injury to neurons ultimately result in the recurrent seizures that characterize epilepsy?

Dr. Coulter has used a variety of approachesphysiological, anatomical and molecularto study the development of epilepsy, both in animal models and in human brains. One technique he has developed in his laboratory is a high-speed imaging method that captures how molecular changes in individual brain cells influence the function of brain signaling networks.

Some of his most recent research has focused on abnormal changes in brain cells called astrocytes reduce inhibition signals in the brain, allowing uncontrolled firing among neurons to give rise to epileptic seizures.

Epilepsy affects an estimated 50 million people, 3 million of them in the United States. It is the third most common neurological disorder, after Alzheimer's disease and stroke.

Dr. Coulter's research has also included studying cellular activities of several anti-epileptic drugs. Coulter said, "The ultimate goal of our research is to help translate detailed knowledge of how epilepsy develops into better therapies for treating children and adults with epilepsy."

Dr. Coulter is an investigator at The Children's Hospital of Philadelphia Research Institute. He also is a professor of Pediatrics and Neuroscience at the University of Pennsylvania School of Medicine, where he directs the University's Center for Dynamic Imaging of Neuronal Function. He has received a Javits Neuroscience Investigator Award of the National Institute of Neurological Disorders and Stroke (NINDS), and was Chair of the second Gordon Research Conference on Epilepsy.

He is active in many educational and scientific activities of the American Epilepsy Society, and has served as an editor of the journals Epilepsy Currents, Epilepsy Research, and Epilepsia, among other publications. He is also a standing member of an NINDS study section.


Contact: John Ascenzi
Children's Hospital of Philadelphia

Related biology news :

1. Rare genetic disorder gives clues to autism, epilepsy, mental retardation
2. Drops in blood oxygen levels may be key to sudden death in some epilepsy patients
3. International team discovers gene associated with epilepsy
4. Epilepsy drug shows potential for Alzheimers treatment
5. Rice University study finds possible clues to epilepsy, autism
6. Researchers discover that gene switches on during development of epilepsy
7. Drug prevents seizure progression in model of epilepsy
8. Rutgers research tackles childhood epilepsy
9. More than fish bait: Worms unlock secrets to new epilepsy treatments
10. Twins provide clue that genetic epilepsy can originate in the embryo
11. Genetic defect found to cause severe epilepsy and mental retardation
Post Your Comments:
Related Image:
Epilepsy researcher at the Children's Hospital of Philadelphia receives scientific prize
(Date:10/29/2015)... OXFORD, Connecticut , October 29, 2015 /PRNewswire/ ... "Company"), a biometric authentication company focused on the ... Wocket® smart wallet announces that StackCommerce, a leading ... will be featuring the Wocket® smart wallet on ... NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:10/27/2015)... 27, 2015 Synaptics Inc. (NASDAQ: SYNA ), ... Google has adopted the Synaptics ® ClearPad ® ... power its newest flagship smartphones, the Nexus 5X by ... --> --> Synaptics works ... strategic collaboration in the joint development of next generation ...
(Date:10/23/2015)... 2015 Research and Markets ( ) ... Recognition Biometrics Market 2015-2019" report to their offering. ... The global voice recognition biometrics market to grow at ... --> --> The report, Global ... on an in-depth market analysis with inputs from industry ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. ... (Nasdaq: HART ), a biotechnology company developing bioengineered ... Jim McGorry will present at the LD ... 2015 at 2:30 p.m. PT. The presentation will be ... 30 days. Management will also be available at the ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, ... will participate in a fireside chat discussion at the ... New York . The discussion is scheduled for ... .  A replay will be available ... Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications and ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... The United ... recipient of the 2016 USGA Green Section Award. Presented annually since 1961, the USGA ... his or her work with turfgrass. , Clarke, of Iselin, N.J., is ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential micronutrient ... to proteins, copper is also toxic to cells. With a $1.3 million award ... will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. ...
Breaking Biology Technology: